HIV & AIDS

Recombinase Brec1 trend-setting for future HIV therapy

Researchers at the Medical Faculty of the Technische Universität Dresden (TUD) and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that ...

Oncology & Cancer

Using Viagra to combat malignant melanoma

Many tumors cause chronic inflammations, which, in their turn, suppress specific attacks against the tumor by the immune system. Scientists at the German Cancer Research Center and Medical Faculty Mannheim at Heidelberg University ...

Oncology & Cancer

CRISPR/Cas9 technology to inactivate cancer mutations

As for many other biomedical and biotechnology disciplines, the genome scissor "CRISPR/Cas9" also opens up completely new possibilities for cancer research. Scientists of the National Center for Tumor Disease (NCT), the German ...

page 1 from 8